Serotonin 2A receptor gene (HTR2A) regulatory variants: Possible association with severity of depression symptoms in children with autism spectrum disorder

Cognitive and Behavioral Neurology

Volumn 27, Issue 2, 2014, Pages 107-116

  Gadow, Kenneth D ^a   Smith, Ryan M ^b   Pinsonneault, Julia K ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

autism spectrum disorder; depression; HTR2A; rs6311; rs6314

Indexed keywords

GENOMIC DNA; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ARTICLE; AUTISM; CHILD; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DSM-IV; EFFECT SIZE; FEMALE; GENE FREQUENCY; GENERALIZED ANXIETY DISORDER; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADULT; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 84903777475     PISSN: 15433633     EISSN: 15370887     Source Type: Journal    
DOI: 10.1097/WNN.0000000000000028     Document Type: Article

References (106)

1. Alvarez JC,Gluck N,Arnulf I,et al.(1999) Decreased platelet serotonin transporter sites and increased platelet in ositol triphosphate levels in patients with unipolar depression: Effects of clomipramine and fluoxetine. Clin Pharmacol Ther. 66, 617-624. (Pubitemid 30014089)
2. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association.
3. Anisman H. 2009. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. Rev Psychiatry Neurosci. 34:4-20.
4. Arias B, Gutierrez B, Pintor L, et al. 2001. Variability in the 5-HT2A receptor gene is associated with seasonal pattern in major depression. Mol Psychiatry. 6:239-242. (Pubitemid 32187878)
5. Attar-Levy D, Martinot JL, Blin J, et al. 1999. The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Biol Psychiatry. 45:180-186. (Pubitemid 29079448)
6. Baganz NL, Blakel y RD. 2013. A dialogue between immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci. 4:48-63.
7. Bakken TL, Helverschou SB, Eilertsen DE, et al. 2010. Psychiatric disorders in adoles cents and adults with autism and intellectual disability: a representative study in one county in Norway. Res Dev Disabil. 31:1669-1677.
8. Belsky J, Jonassaint C, Pluess M, et al. 2009. Vulnerability genes or plasticity genes? Mol Psychiatry. 14:746-754.
9. Belsky J, Pluess M. 2009. Beyond diathesis stress: differential susceptibility to environmental influences. Psychol Bull. 135:885-908.
10. B iver F, Wikler D, Lotstra F, et al. 1997. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry. 171:444-448. (Pubitemid 27475842)
11. Bull SJ, Huezo-Diaz P, Binde r EB, et al. 2009. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-A and ribavirin treatment. Mol Psychiatry. 14:1095-1104.
12. Cadman T, Eklund H, Howley D, et al. 2012. Caregiver burden as people with autism spectrum disorder and attention-deficit/hyperactivity disorder transition into adolescence and adulthood in the United Kingdom. J Am Acad Child Adolesc Psychiatry. 51: 879-888.
13. Cho IH, Yoo HJ, Park M, et al. 2007. Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios . Brain Res. 1139: 34-41.
14. Choi MJ, Lee HJ, Lee HJ, et al. 2004. Association between major depressive disorder and the-1438A/G polymorphism of the serotonin 2A receptor gene. Neuropsychobiology. 49:38-41.
15. Christiansen L, Tan Q, Iachina M, et al. 2007. Candidate gene polymorphisms in the serotonergic pathway: influence on depression symptomatology in an elderly population. Biol Psychiatry. 61: 223-230. (Pubitemid 46072781)
16. Ciarlegio CM, Resuehr HES, McMahon DG. 2011. Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues. Neuroscience. 197:8-16.
17. Cohen J. 1988. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Mahwah, NJ: Lawrence Erlbaum.
18. Cook EH Jr, Arora RC, Anderson GM, et al. 1993. Platelet serotonin studies in hyperserotonemic relatives of children wi th autistic disorder. Life Sci. 52:2005-2015.
19. Cross Disorder Group of the Psychiatric Genetics Consortium. 2013. Identification of risk loci with shared effects on five major psychiatric disorders: a genomic-wide analysis. Lancet. 381:1371-1379.
20. Daniels JL, Forssen U, Hultman CM, et al. 2008. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics. 121:e1357-e1362.
21. Davies MA, Setola V, Strachan RT, et al. 2006. Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies. Pharmacogenomics J. 6: 42-51. (Pubitemid 43118310)
22. Depino AM. 2013. Peripheral and central inflammation in autism spectrum disorders. Mol Cell Neurosci. 53:69-76.
23. DeVincent CJ,Gadow KD(2009) Relative clinical utility of three Child Symp tom Inventory-4 scoring algorithms for differentiating children with autism spectrum disorder versus attention-deficit hyperactivity disorder. Autism Res. 2, 312-321.
24. Dowlati Y, Herrmann N, Swardfager W, et al. 2010. A meta-analysis of cytokines in major depression. Biol Psychiatry. 67:446-457.
25. Dwivedi Y, Mondal AC, Payappagoudar GV, et al. 2005. Differential regulation of serotonin (5HT)2A receptor mRNA and pr otein levels after single and repeated stress in a rat brain: role in learned helplessness behavior. Neuropharmacology. 48:204-214. (Pubitemid 40208256)
26. Eckert A, Gann H, Riemann D, et al. 1993. Elevated intracellular calci um levels after 5-HT2 receptor stimulation in platelets of depressed patients. Biol Psychiatry. 34:565-568. (Pubitemid 23338515)
27. Fiocco AJ, Joober R, Poirer J, et al. 2007. Polymorphism of the 5-HT2A receptor gene: associat ion with stress-related indices in healthy middle-aged adults. Front Behav Neurosci. 1:3.
28. Franke L, Schewe HJ, Müller B, et al. 2000. Serotonergic platelet variables in unmedicated patients suffering from maj or depression and healthy subjects: relationship between 5HT content and 5HT uptake. Life Sci. 67:301-315. (Pubitemid 30413938)
29. Frisch A, Postilnick D, Rockah R, et al. 1999. Association of unipolar major depressive disorder wit h genes of the serotonergic and dopaminergic pathways. Mol Psychiatry. 4:389-392. (Pubitemid 29440581)
30. Gadow KD, DeVincent CJ, Pomeroy J, et al. 2005. Comparison of DSM-IV symptoms in elementary school-aged children with PD D versus clinic and community samples. Autism. 9:392-415. (Pubitemid 41489547)
31. Gadow KD, DeVincent CJ, Siegal VI, et al. 2013. Allele-specific associations of 5-HTTLPR/rs25531 with ADHD and autism spectrum disorder. Prog Neurop sychopharmacol Biol Psychiatry. 40:292-297.
32. Gadow KD, Guttmann-Steinmetz S, Rieffe C, et al. 2012. Depression symptoms in boys with autism spectrum disorder and comparison samples. J Autism Dev Disord. 42:1353-1363.
33. Gadow KD, Roohi J, DeVincent CJ, et al. 2008a . Association of ADHD, tics, and anxiety with dopamine transporter (DAT1) genotype in autism spectrum disorder. J Child Psychol Psychiatry. 49:1331-1338.
34. Gadow KD, Schwartz J, DeVincent C, et al. 2008b . Clinical utility of autism spectrum disorder scoring algorithms for the Child Symptom Inventory. J Autism Dev Disord. 38:419-427. (Pubitemid 351322363)
35. Gadow KD, Sprafkin J. 2002. Child Symptom Inventory-4 Screening and Norms Manual. Stony Brook, NY: Checkmate Plus.
36. Gadow KD, Sprafkin J. 2011. The Symptom Inven tories: An Annotated Bibliography [online]. Stony Brook, NY: Checkmate Plus. Available at: http://www.checkmateplus.com. Accessed January 8, 2014.
37. Girgis RR, Slifstein M, Xu X, et al. 2011. The 5-HT(2A ) receptor and serotonin transporter in Asperger's disorder: a PET study with [(1)(1)C]MDL 100907 and [(1)(1)C]DASB. Psychiatry Res. 194: 230-234.
38. Goines PE, Ashwood P. 2013. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol. 36:67-81.
39. Goldberg J, Anderson GM, Zwaigenbaum L, et al. 2009. Cortical serotonin type-2 receptor density in parents of children with au tism spectrum disorders. J Autism Dev Disord. 39:97-104.
40. Guhathakurta S, Singh AS, Sinha S, et al. 2009. Analysis of serotonin receptor 2A gene (HTR2A): association study with autism spectrum disorder i n the Indian population and investigation of the gene expression in peripheral blood leukocytes. Neurochem Int. 55: 754-759.
41. Hazelwood LA, Sanders-Bush E. 2004. His452Tyr polymorphism in the human 5-HT2A receptor destabilizes the signaling conformation. Mol Pharmacol. 66:1293-1300. (Pubitemid 39411069)
42. Hernandez I, Sokolov BP. 2000. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment. J Neurosci Res. 59: 218-225. (Pubitemid 30036895)
43. Hollingshead AB. Four Factor Index of Social Status. Unpublished working paper from the Department of Sociology, Yale University, New Haven, CT. Available at: http://www.academia.edu/927771/Four-Factor-Index-of-Social-Status. Accessed January 8, 2014.
44. Hranilovic D, Blazevic S, Babic M, et al. 2010. 5-HT2A receptor gene polymorphisms in Croatian subjects with autistic disorder. Psychiatry Res. 178:556-558.
45. Hranilovic D,Bujas-Petkovic Z,Tomicic M,et al.(2009) Hyperserotonemia in autism: Activity of 5HT-associated platelet proteins. J Neural T ransm. 116, 493-501.
46. Hu VW, Sarachana T, Kim KS, et al. 2009. Gene e xpression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res. 2:78-97.
47. Jin C, Wenwei X, Yuan J, et al. 2013. Meta-analysis of association between the-1438A/G (rs6311) polymorphism of the serotonin 2A receptor gene and major depressive disorder. Neurol Res. 35:7-14.
48. Johansson C, Smedh C, Partonen P, et al. 2001. Seasonal affective disorder and serotonin-related polymorphisms. Neurobiol Dis. 8:351-357. (Pubitemid 32382488)
49. Kaat AJ, Gadow KD, Lecavalier L. 2013. Psychiatric symptom impairment in children with autism spectrum disorders. J Abnorm Child Psychol. 41:959-969.
50. Kamata M, Suzuki A, Yoshida K, et al. 2011. Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorder. Affect Disord. 135:374-376.
51. Kato M, Serretti A. 2010. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry. 15:473-500.
52. Kim JM, Stewa rt R, Bae KY, et al. 2012. Serotonergic and BDNF genes and risk of depression after stroke. J Affect Disord. 36: 833-840.
53. Kistner-Griffin E, Brune C, Davis LK, et al. 2011. Parent-of-origin effects of the serotonin transporter gene associated with autism. Am J Med Genet B Neuropsychiatr Genet. 156:139-144.
54. Kronfe ld-Schor N, Einat H. 2012. Circadian rhythms and depression: human psychopathology and animal models. Neuropharmacology. 62:101-114.
55. Kusumi I, Koyama T, Yamashita I. 1994. Serotonin-induced platelet intracellular calcium mobilization in depressed patients. Psychopharmacology (Berl). 113:322-327. (Pubitemid 24150475)
56. Lapin JP, Oxenkrug GF. 1969. Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet. 1:132-136.
57. Lecavalier L, Gadow KD, DeVincent CJ, et al. 2009. Validation of DSM-IV model of psychiatric syndromes in children with autism spectrum disorder. J Autism De v Disord. 39:278-289.
58. Lee H-J, Sung S-M, Lim S-W, et al. 2006. Seasonality associated with the serotonin 2A receptor-1438 A/G polymorphism. J Affect Disord. 95:145-148. (Pubitemid 46107031)
59. Lee L C, Newschaffer CJ, Lessler JT, et al. 2008. Variation in season of birth in singleton and multiple births concordant for autism spectrum disorder. Pediatr Perinat Epidemiol. 22:172-179. (Pubitemid 351640721)
60. Leyfer OT, Folstein SE, Bacalman S, et al. 2006. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord. 36:849-861. (Pubitemid 44440104)
61. Löpez- Muńoz F, Alamo C. 2009. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 15:1563-1586.
62. Lord C, Risi S, Lambrecht L, et al. 2000. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord. 30:205-223.
63. Lugnegard T, Hallerback MU, Gillberg C. 2011. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome. Res Dev Disabil. 32:1910 -1917.
64. Magnusson KM, Constantino JN. 2011. Characterization of depression in children with autism spectrum disorders. J Dev Behav Pediatr. 32:332-340.
65. Maier SF. 2003. Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav Immun. 17:69-85. (Pubitemid 36369416)
66. McBride PA,Anderson GM,Hertzig ME,et al.(1989) Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Arch Gen Psychiatry 46, 213-221. (Pubitemid 19078257)
67. Meltzer CC, Price JC, Mathis CA, et al. 1999. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am J Psychiatry. 156:1871-1878.
68. Meyer JH, Kapur S, E isfeld B, et al. 2001. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am J Psychiatry. 158:78-85. (Pubitemid 32047250)
69. Miller AH, Haroon E, Raison CL, et al. 2013. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety. 30:297-306.
70. Miller GA, Chapman JP. 2001. Misunderstanding analysis of covariance. J Abnorm Psychol. 110:40-48. (Pubitemid 32205156)
71. Minov C, Baghai TC, Schule C, et al. 2001. Serotonin-2A-receptor and-transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett. 303:119-122. (Pubitemid 32320019)
72. Molnar E, Lazary J, Benko A, et al. 2010. Seasonality and winter-type seasonal depression are associated with the rs731779 polymorphism of the serotin-2A receptor gene. Eur Neuropsychopharmacol. 20: 655-662.
73. Muck-Seler D, Jakovljevic M, Pivac N. 1996. Platelet 5-HT concentrations and suicidal behaviour in recurrent major depression. J Affect Disord. 39:73-80. (Pubitemid 26235327)
74. Muck-Seler D, Pivac N, Mustapic M, et al. 2004. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women. Psychiatry Res. 127:217-226. (Pubitemid 39024499)
75. Murphy DGM, Daly E, Schmitz N, et al . 2006. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. Am J Psychiatry. 163:934-936. (Pubitemid 44464547)
76. Narasimhan S, Lohoff FW. 2012. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions. Pharmacogenomics. 13:441-464.
77. National Center for Biotechnology Information. International HapMap Project [online database]. Available at: http://hapmap.ncbi.nlm.nih.gov. Accessed March 5, 2013.
78. Oreland S, Pickering C, Gokturk L, et al. 2009. Two repeated maternal separation procedures differentially affect brain 5-hydroxytryptamine transporter and receptors in young and adult male and female rats. Brain Res. 1305:S37-S49.
79. Oswald P, Souery D, Massat I, et al. 2003. Lack of association between the 5HT2A receptor polymorphism (T102C) and unipol ar affective disorder in a multicentric European study. Eur Neuropsychopharmacol. 13:365-368. (Pubitemid 37040919)
80. Pivac N, Muck-Seler D, Sagud M, et al. 2003. Long-term sertraline treatment and peripheral biochemical markers in female depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 27:759-765. (Pubitemid 36966756)
81. Pjrek E, Winkler D, Heiden A, et al. 2004. Seasonality of birth in seasonal affective disorder. J Clin Psychiatry. 65:1389-1393.
82. Pouw LBC, Rieffe C, Stockmann L, et al. 2013. The link between emotion regulation, social functioning, and depression in boys with ASD. Res Autism Spectr Disord. 7:549-556.
83. Raiso n CL, Miller AH. 2013. The evolutionary significance of depression in pathogen host defense (PATHOS-D). Mol Psychiatry. 18:15-37.
84. Roohi J, DeVincent CJ, Hatchwell E, et al. 2009. Association of a mo noamine oxidase-A gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. J Autism Dev Disord. 39:67-74.
85. Ruljancic N, Mihanovic M, Cepelak I, et al. 2013. Platelet serotonin and magnesium concentrations in suicidal and non-suicidal depressed patients. Magnes Res. 26:9-17.
86. Rutter M, LeCouteur A, Lord C. 2003. Autism Diagnostic Interview-Revised. Los Angeles, CA: Western Psycholo gical Services.
87. Savitz JB, Drevets WC. 2013. Neuroreceptor imaging in depression. Neurobiol Dis. 52:49-65.
88. Schain RJ,Freedman DX(1961) Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr. 58, 315-320.
89. Sheline YI, Mintun MA, Barch DM, et al. 2004. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography. Neuropsychopharmacology. 29:2235-2241. (Pubitemid 39578915)
90. Shimbo D, Chil d J, Davidson K, et al. 2002. Exaggerated serotoninmediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol. 89:331-333. (Pubitemid 34113797)
91. Siegel M, Beaulieu AA. 2012. Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice. J Autism Dev Disord. 42:1592-1605.
92. Simonoff E, Pickles A, Charman T, et a l. 2008. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 47:921-929.
93. Slavich GM, Way BM, Eisenberger NI, et al. 2010. Neural sensitivity to social rejection is associated with inflammatory responses to social stress. Proc Natl Acad Sci USA. 107:14817-14822.
94. Smith RM, Banks W, Hansen E, et al. 2014. Family-based clinical associations and functional characterization of the serotonin 2A receptor gene (HTR2A) in autism spectrum disorder. Autism Res. doi: 10.1002/aur.1383. [Epub ahead of print].
95. Smith RM, Papp AC, Webb A, et al. 2013. Multiple regulatory variants modulate expression of the serotonin 2A receptor gene (HTR2A) in human cortex. Biol Psychiatry. 73:546-554.
96. Spurlock G, Heils A, Holmans P, et al. 1998. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol Psychiatry. 3:42-49. (Pubitemid 28045184)
97. Thanseem I, A nitha A, Nakamura K, et al. 2012. Elevated transcription factor specificity protein 1 in autistic brains alters the expression of autism candidate genes. Biol Psychiatry. 71:410-418.
98. Uebelhack R, Franke L, H erold N, et al. 2006. Brain and platelet serotonin transporter in humans-correlation between [123I]-ADAM SPECT and serotonergic measurements in platelets. Neurosci Lett. 406:153-158. (Pubitemid 44376570)
99. Vargas DL, Nascimbene C , Krishnan C, et al. 2005. Neurological activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 57:67-81. (Pubitemid 40053317)
100. Veenstra-VanderWeele J, Kim SJ, Lord C, et al. 2002. Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism. Am J Med Genet. 114:277-283. (Pubitemid 34258851)
101. Whitaker-Azmitia PM. 2001. Serotonin and brain development: role in human developmental diseases. Brain Res Bull. 56:479-485. (Pubitemid 34031783)
102. Wilkie MJ, Smith G, Day RK, et al. 2009. Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy. Pharmacogenomics J. 9:61-70.
103. Willeit M, Praschak-Rieder N. 2010. Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: a review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry. NeuroImage. 53:878-892.
104. Willins DL, Alsayegh L, Berry SA, et al. 1998. Serotonergic antagonist effects on trafficking of serotonin 5-HT2A receptors in vitro and in vivo. Ann N Y Acad Sci. 861:121-127. (Pubitemid 29047708)
105. Witwer AN, Lecavalier L. 2010. Validity of comorbid psychiatric disorders in youngsters with autism spectrum disorders. J Dev Phys Disabil. 22:367-380.
106. Yatham LN, Liddle PF, Shiah IS, et al. 2000. Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry. 57:850-858.